Pharmaceuticals stories
New Zealand patients could see fewer supply disruptions as locally grown and made medicinal cannabis medicines reach the market for the first time.
Mary Alice Simon's appointment is intended to boost production, quality systems and New Zealand's first medicinal cannabis trials.
Bond markets and prolonged virus disruption could strain weaker firms, with airlines, shipping and non-food retail facing the biggest risk.
New Zealand's medicinal cannabis sector gains a major research boost as Dr James Polston joins Helius after leading R&D at Trulieve.
Auckland billboards fronted by eight patients and advocates aim to reduce stigma as New Zealand's medicinal cannabis laws take shape.
NZ wholesale trade rose 0.7% in Q3, reaching NZD $22.08 billion, driven by a booming auto industry which saw a 2% rise in sales to NZD $1.99 billion.
The high content screening market will register positive growth, with the overall valuation forecast to reach US$1.6 billion in 2022, according to FMI.
Chemist Warehouse has selected Marketplacer to drive the company's new online marketplace throughout Australia and New Zealand.
M2Cloud has announced it has developed an Internet of Things (IoT)-based LTE monitoring system with Thales, optimised for biopharmaceutical monitoring.
Finnish company Logmore is using its cloud service and QR code tags to monitor COVID-19 vaccine shipments in the Asia-Pacific region.